SCHEMBL1418243

SCHEMBL1418243

COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1[N+](=O)[O-]

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 10/20 0.78
▸ FBP1 P09467 3/20 0.74
▸ KDM4E B2RXH2 2/20 0.74
▸ MAPT P10636 2/20 0.74
▸ MAPK1 P28482 2/20 0.74
▸ MEN1 O00255 1/20 0.74
▸ GMNN O75496 1/20 0.74
▸ ALDH1A1 P00352 1/20 0.74
▸ ABL1 P00519 1/20 0.74
▸ LMNA P02545 1/20 0.74
▸ RAF1 P04049 1/20 0.74
▸ TP53 P04637 1/20 0.74
▸ CYP1A2 P05177 1/20 0.74
▸ GLA P06280 1/20 0.74
▸ CYP3A4 P08684 1/20 0.74
▸ CYP2D6 P10635 1/20 0.74
▸ SRC P12931 1/20 0.74
▸ HPGD P15428 1/20 0.74
▸ ALOX15 P16050 1/20 0.74
▸ NFKB1 P19838 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8088219 0.88 EGFR (0.79) EGFRFBP1KDM4EMAPTMAPK1
SCHEMBL19885300 0.88 EGFR (0.78) EGFRFBP1LCKABCG2KDR
SCHEMBL17940088 0.88 EGFR (1.00) EGFRFBP1KDM4EMAPTMAPK1
SCHEMBL26162 0.86 EGFR (0.75) EGFRFBP1KDR
SCHEMBL13514785 0.86 EGFR (0.75) EGFRFBP1KDM4EMAPTMAPK1
SCHEMBL29614965 0.86 EGFR (0.75) EGFRFBP1KDR
SCHEMBL29365524 0.86 EGFR (0.75) EGFRFBP1KDR
Tyrphostin Ag-1478 SCHEMBL93838 0.85 EGFR (1.00) EGFRFBP1KDM4EMAPTMAPK1
Tyrphostin Ag-1478 SCHEMBL31079458 0.85 EGFR (1.00) EGFRFBP1KDM4EMAPTMAPK1
Tyrphostin Ag-1478 SCHEMBL29350062 0.85 EGFR (1.00) EGFRFBP1KDM4EMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298746-A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-03-23 — — EP disclosed
US-6972288-B1 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-12-06 — — US disclosed
EP-1157011-A1 4-AMINO- QUINAZOLINE AND QUINOLINE DERIVATIVES HAVING AN INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES Boehringer Ingelheim Pharma KG (DE) 2001-11-28 — — EP disclosed
WO-2000051991-A1 4-AMINO-QUINAZOLINE AND QUINOLINE DERIVATIVES HAVING AN INHIBITORY EFFECT ON SIGNAL TRANsSDUCTION MEDIATED BY TYROSINE KINASES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-08 — — WO disclosed
Send feedback